Brief: Cleo Diagnostics Files Patents For Its Ovarian Cancer Screening Test
30/09/2026 02:37
BRIEF-Cleo Diagnostics Files Patents For Its Ovarian Cancer Screening Test Sept 30 (Reuters) - Cleo Diagnostics Ltd COV.AX:
FILES PATENTS FOR ITS OVARIAN CANCER SCREENING TEST
Further company coverage: COV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CLEO Diagnostics
See all newsAustralia's Cleo Diagnostics jumps after cancer screening test meets milestone
Brief: Cleo Diagnostics Files Patents For Its Ovarian Cancer Screening Test
Australia's Cleo Diagnostics jumps as ovarian cancer test hits validation milestone
Brief: Cleo Diagnostics Receives First Batch Of Commercially Manufactured Test Kits
Brief: Cleo Diagnostics Raises A$5M